GlassScriptPhysician profile
Stephen Hurlbut
NPI 1699750836
$6,467.23
in general payments reported to CMS, 2019-2025
51 companies · $1,439 in 2025
The $1,439 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,005 · 2020: $131 · 2021: $48.66 · 2022: $1,067 · 2023: $1,281 · 2024: $1,495 · 2025: $1,439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,158 · Education: $57.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,158.39 |
| Education | $57.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,769.37 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $529.61 | 2019-2025 | Ajovy, Austedo Xr, Austedo |
| Tg Therapeutics, INC. | $405.33 | 2024-2025 | |
| Emd Serono, INC. | $282.35 | 2019-2024 | |
| Biogen, INC. | $263.92 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Lilly USA, LLC | $237.86 | 2019-2024 | Kisunla, Emgality |
| Novartis Pharmaceuticals Corporation | $231.78 | 2019-2025 | |
| Vanda Pharmaceuticals INC. | $214.84 | 2025 | Ponvory |
| Pfizer INC. | $174.76 | 2019-2025 | |
| Genentech USA, INC. | $169.33 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Amgen INC. | $168.45 | 2020-2024 | Uplizna |
| Ucb, INC. | $161.86 | 2019-2024 | Briviact |
| Genzyme Corporation | $151.31 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $149.84 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $120.34 | 2019-2025 | Nuplazid |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Hurlbut listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.